SARS-CoV-2 belongs to the family of enveloped, single-strand RNA viruses known as
Betacoronavirus in Coronaviridae, first reported late 2019 in China. It has since been …

Inflammation contributes centrally to cardiovascular diseases, and anti-inflammatory
treatments can reduce cardiovascular events. The JAK–STAT pathway is an emerging target …

As SARS-CoV-2 continues to cause morbidity and mortality around the world, there is an
urgent need for the development of effective medical countermeasures. Here, we assessed …

The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …

Tocilizumab has been repurposed against the 'cytokine storm'in the setting of coronavirus
disease 2019 (COVID‐19). Our aim was to evaluate the efficacy of tocilizumab in the …

Abstract Purpose The Coronavirus disease 2019 (COVID-19) pandemic is one of the most
devastating global problems. Regarding the lack of disease-specific treatments, repurposing …

Researchers from the world over are working to create prophylactic and therapeutic
interventions to combat the COVID-19 global healthcare crisis. The current therapeutic …

With an epidemic spread, metabolic syndrome represents an increasingly emerging risk for
the population globally, and is currently recognized as a pathological entity. It is represented …

Background Due to the high incidence and mortality of the worldwide COVID-19 pandemic,
beneficial effects of effective antiviral and anti-inflammatory drugs used in other diseases …

The lumen of the gastrointestinal (GI) tract contains an incredibly diverse and extensive
collection of microorganisms that can directly stimulate the immune system. There are …